Radiation visits—much like preventative screenings, surgery, chemotherapy and screening—were delayed or canceled at the peak of COVID-19 in the United States.
Nicole Kuderer and colleagues are to be congratulated for their report—in The Lancet and at the ASCO 2020 Annual Meeting—on the impact of COVID-19 on a cohort of patients with cancer.
The first COVID-19 patient walked into a Mount Sinai ER on March 1.
A telesitevisit? No, this is not a typo.
Programs designed to meet the NCI Community Outreach and Engagement requirements for cancer center designation have positioned the University of Miami Sylvester Comprehensive Cancer Center to monitor the prevalence of SARS-CoV-2 in South Florida.
In Georgia, COVID-19 did something different.
As the healthcare system faces the onslaught of the novel coronavirus SARS-CoV-2, clinicians caring for individuals with cancer face the challenge of a wide gap in knowledge needed to guide decision-making.
On a chaotic COVID weekend two months ago, a friend’s child (a young, talented black and Latino student athlete) came home from college not feeling well. The young man’s mother, an executive administrative assistant, called off work to stay home with him because of his, as she described, “full-blown flu-like symptoms.”
Oncology pioneer John W. Yarbro, MD, PhD, died April 13 in Miramar Beach, Florida. He was 88.
We moved to Houston together with Rosemary's daughters, Catharine and Claire, in August of 1983 when Irv accepted the position of head of the Division of Medicine at MD Anderson Cancer Center.
